Fig. 7
DMAb combination with antibiotic regimen. a BALB/c mice were injected with control DMAb-DVSF3 (100 µg), saline + MEM (2.3 mg kg−1), DMAb-BiSPA (100 µg), or DMAb-BiSPA (100 µg) + MEM (2.3 mg kg−1) and then challenged with a lethal dose of P. aeruginosa 6077. MEM was administered 1 h post lethal challenge. Animals were monitored for 144 h post infection. n = 8 mice/group. b DMAb serum levels in animals before lethal challenge. n = 8 mice/group. The line represents the mean value and error bars represent standard deviation
